Sun Pharma Advanced Research Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Anilkumar Raghavan
Chief executive officer
₹50.2m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 10.1yrs |
| CEO ownership | n/a |
| Management average tenure | 4.3yrs |
| Board average tenure | 9.6yrs |
Recent management updates
Recent updates
Sun Pharma Advanced Research (NSE:SPARC) Is In A Good Position To Deliver On Growth Plans
Jan 17
Sun Pharma Advanced Research Company Limited's (NSE:SPARC) Business Is Trailing The Industry But Its Shares Aren't
Nov 14Is Sun Pharma Advanced Research (NSE:SPARC) Using Too Much Debt?
Sep 05Here's Why We're Not At All Concerned With Sun Pharma Advanced Research's (NSE:SPARC) Cash Burn Situation
Jun 27Is Sun Pharma Advanced Research (NSE:SPARC) A Risky Investment?
Nov 23If You Had Bought Sun Pharma Advanced Research's (NSE:SPARC) Shares Three Years Ago You Would Be Down 57%
Feb 08
Do Institutions Own Sun Pharma Advanced Research Company Limited (NSE:SPARC) Shares?
Dec 14CEO
Anilkumar Raghavan (55 yo)
10.1yrs
Tenure
₹50,167,000
Compensation
Mr. Anilkumar Raghavan has been the Chief Executive Officer of Sun Pharma Advanced Research Company Limited since April 24, 2014. Mr. Raghavan is a senior pharmaceutical services executive with significant...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 10.1yrs | ₹50.17m | no data | |
| Chief Financial Officer | 7.3yrs | ₹15.14m | no data | |
| Executive Vice President Clinical Development & Operations | 2.6yrs | no data | no data | |
| Senior General Manager of Business Development | no data | no data | no data | |
| Chief Human Resource Officer | 4.3yrs | no data | no data | |
| Executive VP and Head Operational Excellence & COE's | no data | no data | no data | |
| Executive VP & Chief Innovation Officer | no data | no data | no data | |
| Senior Vice President of Drug Delivery System | no data | no data | no data | |
| Senior VP & Head of Translational Development | 5.1yrs | no data | no data | |
| Executive VP & Global Head of Drug Discovery and Preclinical Development | 1.2yrs | no data | no data | |
| Company Secretary | less than a year | no data | no data |
4.3yrs
Average Tenure
Experienced Management: SPARC's management team is considered experienced (4.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 18.2yrs | ₹330.00k | 19.06% ₹ 14.4b | |
| Non-Executive Director | 18.2yrs | ₹690.00k | 1.84% ₹ 1.4b | |
| Independent Director | 3.9yrs | ₹540.00k | no data | |
| Independent Director | 9.6yrs | ₹630.00k | no data | |
| Non-Executive Non-Independent Director | 16.9yrs | ₹360.00k | 0.011% ₹ 8.3m | |
| Independent Director | 7yrs | ₹540.00k | no data | |
| Member of Advisory Board | 3.4yrs | ₹570.00k | no data |
9.6yrs
Average Tenure
67.5yo
Average Age
Experienced Board: SPARC's board of directors are considered experienced (9.6 years average tenure).